Abstract
Human parvovirus B19 was discovered by Cossart et al in 1975 while they were evaluating a false-positive result in a counterimmu-noelectrophoresis screening test for hepatitis B antigen1; however, it was not until 1981 that another chance discovery led to the first link between parvovirus B19 and human disease. It was the discovery of viremia in two children attending a clinic in London that led to the description of six cases of aplastic crisis associated with parvovirus B19 infection in children with sickle cell anemia.2 In 1983, erythema infectiosum, or fifth disease, a common childhood exanthem, was shown to be caused by parvovirus B19 infection.3 In 1985, parvovirus B19 infection was linked to acute arthritis, especially in adults.4,5 The first reports of adverse pregnancy outcomes associated with parvovirus B19 infection were published in 1984, when parvovirus B19 infection was linked to cases of hydrops fetalis and fetal death.6,7.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cossart YE, Field AM, Cant B, et al. Parvovirus-like particles in human sera. Lancet. 1975; 1: 72.
Pattison JR, Jones SE, Hodgson J, et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981; 1: 664–665.
Anderson MJ, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet. 1983; 1: 1378.
Reid DM, Reid TMS, Brown T, et al. Human parvovirus-associated arthritis: A clinical and laboratory description. Lancet. 1985; 1: 422.
White DG, Woolf AD, Mortimer PP, et al. Human parvovirus arthropathy. Lancet. 1985; 1: 419–421.
Brown T, Anand A, Ritchie LD. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984; 2: 1033.
Knott PD, Welply GAC, Anderson MJ. Serologically proved intrauterine infection with parvovirus. Br Med J. 1984; 289: 1660.
Berns KI. Parvoviridae and their replication. In: Fields BN, Knipe DM, eds. Fields’ Virology. 2nd ed. New York: Raven Press; 1990; 2: 1743.
Pattison JR. Parvoviruses—Medical and biological aspects. In: Fields BN, Knipe DM, eds. Fields’ Virology. 2nd ed. New York: Raven Press; 1990; 2: 1765.
Shade RO, Blundell MC, Cotmore SF, et al. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1986; 58: 921.
Shapiro L. The numbered diseases: First through sixth. JAMA. 1965; 194: 210.
Centers for Disease Control. Risks associated with human parvovirus B19 infection. MMWR Morb Mortal Wkly Rep. 1989; 38: 81–97.
Ager EA, Chin TDY, Poland JD. Epidemic erythema infectiosum. N Engl J Med. 1966; 275: 1326–1331.
Chorba T, Coccia R, Holman RC, et al. The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis. 1986; 154: 383–393.
Cramp HE, Armstrong BDJ. Erythema infectiosum: An outbreak of “slapped cheek” disease in north Devon. Br Med J. 1976; 1: 885–886.
Lauer BA, MacCormack JN, Wifert C. Erythema infectiosum: An elementary school outbreak. Am J Dis Child. 1976; 130: 252–254.
Lefrere JJ, Courouce AM, Bertrand Y, et al. Human parvovirus and aplastic crisis in chronic hemolytic anemias: A study of 24 observations. AmJHematol. 1986; 23: 271–275.
Anderson MJ, Lewis E, Kidd IM, et al. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Camb). 1984; 93: 85–93.
Gillespie SM, Cartter ML, Asch S, et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA. 1990; 263: 2061–2065.
Courouce AM, Ferchal F, Morinet F, et al. Human parvovirus infections in France. Lancet. 1984; 1: 160.
Okabe N, Koboyaski S, Tatsuzawa O, et al. Detection of antibodies to human parvovirus in erythema infectiosum (fifth disease). Arch Dis Child. 1984; 59: 1016–1019.
Anderson MJ, Cohen BJ. Human parvovirus B19 infections in United Kingdom 1984-86 (letter). Lancet. 1987; 1: 738–739.
Naides SJ. Erythema infectiosum (fifth disease) occurrence in Iowa. Am J Public Health. 1988; 78: 1230–1231.
Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985; 152: 257–265.
Saarinen UM, Chorba TL, Tattersall P, et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986; 67: 1411–1417.
Potter CG, Potter AC, Hatton CSR, et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest. 1987; 79: 1486–1492.
Young N, Harrison M, Moore J, et al. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest. 1984; 74: 42–24.
Young N, Ozawa K. Studies of B19 virus in bone marrow cell culture. In: Pattison Jr, ed. Parvoviruses and Human Disease. Boca Raton, FL: CRC Press; 1988; 117–132.
Pattison JR, ed. Parvovirus and Human Disease. Boca Raton, FL: CRC Press; 1988.
Ozawa K, Lurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood. 1987; 70: 384–391.
Anderson MJ, Davis LR, Hodgson J, et al. Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol. 1982; 35: 744–749.
Lefrere JJ, Courouce AM, Bertrand Y, et al. Human parvovirus and aplastic crisis in chronic hemolytic anemias: A study of 24 observations. AmJHematol. 1986; 23: 271–275.
Rao KRP, Patel AR, Anderson MJ, Hodgson J, Jones DE, Pattison JR. Infection with a parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med. 1983; 98: 930–932.
Duncan JR, Capellini MD, Anderson MJ, Potter CG, Kurtz JB, Weatherall DJ. A plastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet 1983; 2: 14–16.
Green DH, Bellingham AJ, Anderson MJ. Parvovirus infection in a family with aplastic crisis in an affected sibling pair with hereditary spherocytosis. J Clin Pathol. 1984; 37: 1144–1146.
Kurtzman GJ, Cohen B, Meyers P, et al. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukemia. Lancet. 1988; 2: 1159.
Kurtzman GJ, Ozawa K, Cohen B, et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 1987; 317: 287.
Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients with human immunodeficiency virus type I (HIV-I): A treatable cause of anaemia. Ann Intern Med. 1990; 113: 926.
Gray ES, Davidson RJL, Anand A. Human parvovirus and anaemia. Lancet. 1987; 1: 1144.
Carrington D, Gilmore DH, Whittle MJ, et al. Maternal serum alpha-fetoprotein: A marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet. 1987; 1: 433.
Peters MT, Nicolaides KH. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection. Obstet Gynecol. 1990; 75: 501.
Sahakian V, Weiner CP, Naides SJ, Williamson RA, Scharosch LL. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection. Am J Obstet Gynecol. 1991; 164: 1090–1091.
Naides SJ, Weiner CP. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondar to fetal parvovirus B19 infection Prenat Diag. 1989; 9: 105–114.
Anderson MJ, Lewis E, Kidd IM, et al. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Camb). 1984; 93: 85–93.
Plummer FA, Hammond GW, Forward K, et al. An erythema infectiosum-like illness caused by human parvovirus infection. NEngl J Med. 1985; 313: 74.
Wadlington WB. Erythema infectiosum. JAMA. 1965; 192: 58–66.
Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Inten Med. 1989; 149: 1153–1156.
Eastmond CJ. Human parvovirus-associated arthritis: A clinical and laboratory description. Lancet. 1985; 1: 422–425.
Singer K, Motulsky AG, Wile SA. Aplastic crisis in sickle anemia: A study of its mecha- misms and its relationship to other types of hemolytic crisis. J Lab Clin Med. 1950; 35: 721–736.
Serjeant GR, Topley JM, Mason K, et al 11. Parvovirus Outbreak of aplastic crisis in sickle cell anaemia associated with parvovirus-like agent. Lancet. 1981; 2: 595–597.
Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol. 1988; 25: 159–172.
Serjeant GR, Goldstein AR. B19 virus infection and aplastic crisis. In: Pattison JR, ed. Parvoviruses and Human Disease. Boca Raton, FL: CRC Press; 1988.
Saunders PWG, Reid, MM, Cohen BJ. Human parvovirus induced cytopenias: A report of 5 cases. Br J Haematol. 1986; 63: 407–410.
Koch WC, Adler SP. Detection of human parvovirus B19 DNA by using the polymerase chain reaction. J Clin Microbiol. 1990; 28: 65.
Kurtzman G, Frickhofen N, Kimball J, et al. Pure red-cell aplasia of 10 years’ duration due to persistent parvovirus B19 infection and its cure with immunoglobin therapy. N Engl J Med. 1989; 321: 519.
Koch WC, Massey G, Russell CE, et al. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J. Pediatr. 1990; 116: 355.
Rodis JF, Hovick TJ, Quinn DL, et al. Human parvovirus infection in pregnancy. Obstet Gynecol. 1988; 2: 733.
Margolis G, Kilham L. Problems of human concern arising from animal models of intrauterine and neonatal infections due to viruses: A review. II. Pathological studies. Prog Med Virol. 1975; 20: 144.
Anand A, Gray ES, Brown T, et al. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med. 1987; 316: 183.
Anderson LJ, Hurwitz ES. Human parvovirus B19 and pregnancy. Clin Perinatol. 1988; 15: 273.
Bernstein IM, Capeless EL. Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B19 infection. Obstet Gynecol. 1989; 74; 456.
Bond PR, Caul EO, Usher J, et al. Intrauterine infection with human parvovirus. Lancet. 1986; 1: 448.
Brown T, Ritchie LD. Infection with parvovirus during pregnancy. Br Med J. 1985; 290: 559.
Franciosi RA, Tattersall P. Fetal infection with human parvovirus B19. Hum Pathol. 1988; 19: 489.
Gray ES, Anand A, Brown T. Parvovirus infections in pregnancy. Lancet. 1986; 1: 208.
Lefrere JJ, Damez Y, Courouce AM, et al. Intrauterine infection with human parvovirus. Lancet. 1986; 1: 449.
Maeda H, Shimokowah, Satoh S, et al. Non- immunologic hydrops resulting from intrauterine human parvovirus B19 infection: Report of two cases. Obstet Gynecol. 1988; 72: 482.
Mortimer PP, Cohen BJ, Buckley MM, et al. Human parvovirus and the fetus. Lancet. 1985; 2: 1012.
Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J. 1990; 300: 1166.
Public Health Laboratory Service Working party on Fifth Disease. Study of human parvovirus (B19) infection in pregnancy. Community Dis Rep. 1987; 87: 3.
Rodis JF, Quinn DL, Gary GW, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: A prospective study. Am J Obstet Gynecol. 1990; 163: 1168–1171.
Samra IS, Obhrai MS, Constatine G. Parvovirus infection in pregnancy. Obstet Gynecol. 1989; 5: 832–834.
Weiland HT, Verney-Keers C, Salimans MMM, et al. Parvovirus B19 associated with fetal abnormality. Lancet. 1987; 1: 682.
Wright EP, Dyson AJ, Alaily A. Infection with parvovirus during pregnancy Br J Med. 1985; 290: 241.
Humphrey W, Magoon M, O’Shaughnessy R. Severe nonimmune hydrops secondary to parvovirus B19 infection: Spontaneous reversal in utero and survival of a term infant. Obstet Gynecol 1991; 78; 900–920.
Sheikh AU, Ernest JM, O’Shea M. Long term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol. 1992; 167: 337–340.
Weinbaum PJ, Keenank, Samelson R, Pin-heiro S. Nonimmune hydrops fetalis: Spontaneous resuolution after intrauterine infection with parvovirus B19. J Matern Fetal Med. 1992; 1: 96–99.
Schwarz TF, Roggendorf M, Hottentrager B, et al. Human parvovirus B19 infection in pregnancy. Lancet. 1988; 2: 566.
Clewley JP, Cohen BJ, Field AM. Detection of parvovirus B19 DNA, antigen and particles in the human fetus. J Med Virol. 1987; 23: 367–376.
Porter HJ, Quantrill AM, Fleming KA. B19 parvovirus infection of myocardial cells. Lancet. 1988; 1: 535–536.
Lenghaus C, Studdert MJ. Acute and chronic viral myocarditis. Acute diffuse nonsuppurative myocarditis and residual myocardial scarring following infection with canine parvovirus. Am Jpathol. 1984; 115: 316–319.
Lenghaus C, Studdert MJ, Finnie JW. Acute and chronic canine parvovirus myocarditis following intrauterine inoculation. Aust Vet J. 1980; 56: 465–468.
Schwarz TF, Nerlich A, Hottentrager B, et al. Parvovirus B19 infection of the fetus: Histology and in situ hybridization. Am J Clin Pathol 1991; 96: 121–126.
Van Elsacker-Niele AM, Salimans MMM, Weiland MT, Vermey-Keers C, Anderson MJ, Versteeg J. Fetal pathology in human parvovirus B19 infection. Br J Obstet Gynecol. 1989; 96: 768–775.
Caul EO, Usher J, Burton PA. Intrauterine infection with human parvovirus B19: A light and electron microscope study. J Med Virol. 1988; 24: 55.
Field AM, Cohen BJ, Brown KE, et al. Detection of B19 parvovirus in human fetal tissues by electron microscopy. J Med Virol. 1991; 35: 85–95.
Knisely AS, O’Shea PA, McMillan P, Singer DB. Electron microscopic identification of parvovirus virions in erythroid-line cells in fatal hydrops fetalis. Pediatr Pathol. 1988; 8: 163–170.
Metzman R, Anand A, DeGuilio PA, Knisely AS. Hepatic disease associated with intrauterine parvovirus B19 infection in a newborn premature infant. J Pediatr Gastroenterol Nutr. 1989; 9: 112–114.
Naides SJ, Cuthberson G, Murray JC, Staple-ton JT. Neonatal sequelae of parvovirus B19 infection in utero (abstract). Am Soc Microbiol. 1988; 199.
Anderson LJ, Tson C. Parker RA, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986; 24: 522–526.
Cohen BJ, Mortimer PP, Pereira MS. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg(Camb). 1983; 91: 113–130.
Nascimento JP, Hallam NF, Mori J, et al. Detection of B19 parvovirus in human fetal tissues by in situ hydridization. J Med Virol. 1991; 33: 77–82.
Clewley JP. Detection of human parvovirus using a molecularly cloned probe. J Med Virol. 1985; 15: 173.
Salimans MM, Holsappel S, Van de Rijke FM, et al. Rapid detection of human parvovirus B19 DNA by dot-hybridization and the polymerase chain reaction. J Virol Methods. 1989; 23: 19.
Clewley JP. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol. 1989; 27: 2647.
Kajigaya S, Shimada T, Fujita S, et al. A genetically engineered all cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sei USA. 1989; 86: 7601.
Schwarz TF, Roggendorf M, Hottentrager B, Modrow S, Deinhardt F, Middeldorp J. Immunoglobulins in the prophylaxis of parvovirus B19 infection. J Infect Dis. 1990; 162: 1214.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Rodis, J.F., Vintzileos, A.M. (1994). Parvovirus. In: Gonik, B. (eds) Viral Diseases in Pregnancy. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2640-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2640-6_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7620-3
Online ISBN: 978-1-4612-2640-6
eBook Packages: Springer Book Archive